The disclosure demonstrates the role of cathelicidin, serine protease and/or vitamin D3 in rosacea pathology.

 
Web www.patentalert.com

< USE OF ISOINDOLES FOR THE TREATMENT OF NEUROBEHAVIORAL DISORDERS

> Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions

> CRYSTALLINE FORM OF (2S)-(-)-N-(6-CHLORO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-YLMETHYL)-SULFAMIDE
~ 00569